MarketsSingle-source
2.0
Outlook Therapeutics reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·1 day ago
RUM Group Inc. filed an 8-K form disclosing a change in corporate governance under Item 5.02, indicating the departure of a director or officer. The specific identity of the individual and the circumstances of the departure remain to be verified through the full filing text.